First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation StudyAmit Khot, Simon J. Harrison, Richard B. Pearson et al.|Cancer Discovery|2019Cited by 201